CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2 Open-Label Pilot Study of the Safety and Tolerability of Ixazomib Administered Orally to Patients With Scleroderma-Related Interstitial Lung Disease
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04837131
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:38.674597+00:00
- Published At
- 2025-04-06T00:00:00+00:00
- Record Updated At
- 2025-04-06
- Results Posted At
- 2025-04-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Systemic Sclerosis", "Scleroderma", "Diffuse Systemic Sclerosis", "Diffuse Scleroderma", "Diffuse Cutaneous Systemic Sclerosis", "Diffuse Cutaneous Scleroderma", "Progressive Systemic Sclerosis", "Progressive Scleroderma", "Scleroderma, Systemic", "Scleroderma, Diffuse", "Scleroderma;Progressive", "Systemic Sclerosis, Diffuse", "Systemic; Sclerosis, Progressive", "Scleroderma of Lung", "Scleroderma With Pulmonary Involvement", "Systemic Sclerosis Pulmonary", "Systemic Sclerosis With Lung Involvement", "Interstitial Lung Disease", "Pulmonary Fibrosis Interstitial"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-06"- protocolSection.identificationModule.nctId
"NCT04837131"- protocolSection.identificationModule.officialTitle
"A Phase 2 Open-Label Pilot Study of the Safety and Tolerability of Ixazomib Administered Orally to Patients With Scleroderma-Related Interstitial Lung Disease"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-04-06"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.